Seguridad, tolerabilidad, eficacia y farmacocinética de imipenem/cilastatina/relebactam en participantes pediátricos con infección causada por bacterias gramnegativas
The primary purpose of this study is to evaluate the safety and tolerability of imipenem/cilastatin/relebactam (IMI/REL) in participants from birth to less than 18 years of age with confirmed or suspected